Experience of terahertz therapy in benign prostatic hyperplasia combined with chronic abacterial prostatitis

Abstract

Objective: to improve the treatment results of patients with benign prostatic hyperplasia (stage l-ll) accompanied with chronic abacterial prostatitis (category III A) by the use of terahertz therapy at frequencies of molecular spectrum of emission and absorption of nitric oxide 150,176-150,664 GHz. Material and methods. Atotal number of 75 patients met the inclusion criteria and were available for analysis. They were divided into three groups: 1st core group — 25 patients with BPH (stage l-ll) accompanied with chronic abacterial prostatitis (category III), which received standard medical therapy in combination with THZ-therapy; second group — 25 patients with BPH (stage l-ll) accompanied with CAP, which received standard medical therapy; third control group — 25 healthy men. Results. The combination of THZ — therapy with standard medical treatment allowed us to achieve marked improvements in the IPSS and QoL system, rapid anesthetic effect, more significant volume reduction of the prostate tissue in the 1st core group. Also THZ-therapy in 1st core group revealed a statistically significant increase of the maximum speed of blood vessels in the prostate tissue, improved a prostate secretion and rheological properties of blood. Conclusion. THZ-therapy as a complementary treatment has a beneficial effect on the clinical course of BPH (stage l-ll) accompanied with CAP (category III).

Keywords

• benign prostatic hyperplasia (BPH)
• chronic abacterial prostatitis (CAP)
• terahertz therapy (THZ-therapy)